ASHG 2026 has ended. This guide stays up as the record of who was there. Next: ASHG 2027, Oct 26–30, 2027 in Nashville

LabCorp at ASHG 2026

Oct 20–24, 2026 Montréal, Canada ~7.5k attendees Website

LabCorp brings 17 presentations to ASHG 2026 in Montréal, and exhibits at Booth 1024. Its ASHG 2026 program centres on rare disease, cancer, and clinical genetics, with applications in therapeutics and reproductive testing. Its presentations examine genomic testing in 1.8 million people and cancer biomarker disparities across ancestries, and its hosted session describes a Fabry disease phenotype found in real-world genomics data.

OrganizationASHG 2026 Attendance
LabCorp
Burlington, North Carolina
1 Lab Director · 1 Senior Applied Research Scientist in Oncology · 1 Data scientist · 1 Statistical Geneticist · 3 other presenters
Public company~71,000 people
Labcorp is a global leader of innovative and comprehensive laboratory services that helps doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions.
Labcorp is collaborating with OHSU on a study evaluating blood-based MRD testing for earlier detection of bladder-cancer recurrence.
›
Labcorp is collaborating with OHSU on a study evaluating blood-based MRD testing for earlier detection of bladder-cancer recurrence.
2026-09 · source
Labcorp acquired MLM Medical Labs, a global central and specialty laboratory provider, expanding its central-lab capacity for trial sponsors.
2026-09 · source
Labcorp enhanced its Global Trial Connect platform, upgrading the digital tools it offers clinical-trial sponsors and data teams.
2026-08 · source
Source: company newsroom
Q2 2026 revenue $3.73B, up 5.8%
›
FY2026 revenue-growth guidance of 5.4%-6.3% points to continued expansion of its testing and trial services. · 2026-07-30
“Revenue: $3.73 billion vs. $3.53 billion, up 5.8%; Annual revenue growth guidance of 5.4% to 6.3%.”
Source: results release
Booth
Exhibiting at Booth 1024
Wed, Oct 219:30am–4:30pmThu, Oct 229:30am–6:15pmFri, Oct 239:30am–4:30pm
Poster
Wed Oct 21
2:30 pm
Poster
Wed Oct 21
2:30 pm
Poster
Wed Oct 21
2:30 pm
Poster
Wed Oct 21
2:30 pm
From global calibration to gene-aware evidence: calibrating pathogenicity predictions for real-world variant interpretation
Artificial intelligenceVariant interpretationMethodologyGenetic testing
Talk
Thu Oct 22
2:15 pm
Surveying the structural variant landscape in genetic testing: Prevalence and diagnostic yield in a clinical cohort of 1.8 million individuals
Clinical geneticsCopy number/structural variationDiagnosticsGenetic testing
Poster
Thu Oct 22
4:15 pm
★ Reviewers’ Choice
The impact of an iterative points-based framework on variant classification outcomes for neurodevelopmental disorders.
Artificial intelligenceVariant interpretationNeurodevelopmentalClinical testing
Poster
Thu Oct 22
4:15 pm
Applying Single Cell Transcriptomics and Machine Learning to Classify SCN1A Variants According to Disease Mechanism
Laboratory genetics and genomicsGenomicsMachine learningGenetic variation
Poster
Thu Oct 22
4:15 pm
A machine learning framework for accurate SMN1 copy number determination from short-read next-generation sequencing data
BioinformaticsCopy number/structural variationGenomicsMachine learning
Poster
Thu Oct 22
4:15 pm
Biochemical data and genetic testing: combining datasets to help classify variants
Laboratory genetics and genomicsVariant interpretationPhenotypeMetabolic disorder
Poster
Fri Oct 23
2:30 pm
Assessment of Structural and Copy Number Variants in Constitutional Samples Using Electronic Genome Mapping
AneuploidyChromosomal abnormalitiesClinical testingCopy number/structural variation
Poster
Fri Oct 23
2:30 pm
Validating gain- and loss-of-function multiplexed assay of variant effect (MAVE) predictions using linked genetic testing and biochemical datasets: a CASR case study
Variant interpretationGenotype-phenotype correlationsMendelian disorderRare variants
Poster
Fri Oct 23
2:30 pm
Evidence supporting RPS20 as a colorectal cancer susceptibility gene from a case-control study
Collaborators: University of Pittsburgh
CancerCancer syndromesGenetic epidemiologyGenetic testing
Poster
Fri Oct 23
2:30 pm
A conversational AI agent for multi-domain clinicogenomic research analytics with layered human-in-the-loop verification
Artificial intelligenceComputational toolsDatabasesGenotype-phenotype correlations
Poster
Fri Oct 23
2:30 pm
Single-cell transcriptomic variant effect mapping of clinically relevant MSH3 variants
Machine learningMassively parallel sequencingVariant interpretation

Explore the full ASHG 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Montréal. Leave your work email and we’ll be in touch.

Privacy

Download the full ASHG 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at LabCorp

Tell us what you sell and we’ll find the people at LabCorp most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the American Society of Human Genetics. Submit a correction